Specifically, comparison of 52 paired normal and tumor samples showed that the majority of them [approximately 56% (29 out of 52)] exhibited an increased expression of HDAC3 at the mRNA level in tumors (Fig EV1B), suggesting that HDAC3 is a highly relevant protein in prostate cancer. Here, HDAC3 is linked to prostate cancer.